Sonivie

Developer of denervation catheter for the treatment of pulmonary hypertension

placeRosh Haayin, Center District, Israel calendar_todayFounded 2014 groups13 employees language sonivie.com

Innovation

9 patent families (8 granted) — focus: Human necessities; filing pace slowing. Cited 5,620 times.

YearFilings
20151
20171
20181
20192
20202
20212
20223
20235
20241
20255
20261

Investor mix

7 investors on record; lead investors include Andera Partners; 2 have since exited.

Investor typeCountShare
Venture capital457%
Private equity229%
Other / undisclosed114%
Coming soon